Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

A single-group, phase 1–2 study indicated that eltrombopag improved the efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) plus cyclosporine in patients ...

Dr Sandip Shah said aplastic anemia can affect anyone, but is more common in younger adults. Symptoms include fatigue, shortness of breath and bleeding.

Aplastic anaemia is a rare, life‐threatening disorder of the bone marrow characterised by pancytopenia and a hypocellular marrow. The primary pathophysiology involves immune-mediated destruction of ...

Severe aplastic anemia used to have few options and mortality was high, but a new class of drugs offers some hope. A recent review examined treatment options for aplastic anemia (AA), a hematopoietic ...

A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival ...

Kolkata (West Bengal) [India], December 30: Dr. A. K. Dwivedi, a senior and widely respected Homoeopathic physician, Professor and Head of the Department of Physiology & Biochemistry, and Director & ...

Anaemia is not always caused by low iron. A doctor explains the warning signs, causes, and risks of aplastic anaemia, a rare but serious blood disorder.

Aplastic anemia is a rare disorder characterized by inadequate production of blood cells by the bone marrow. The bone marrow is a spongy tissue inside the bones, where all the blood cells (red blood ...